Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Oesterreichische Kontrollbank $1 billion notes offering
The 4.25% notes are due 2028
Pepkor Holdings ZAR 4.9 billion secondary offering
The accelerated bookbuild transaction represented approximately 7.2% of Pepkor’s issued share capital
IONOS Group €447 million IPO
The shares are listed on the Frankfurt Stock Exchange
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Deutsche Bank $1.5 billion subordinated Tier 2 notes offering
The 7.079% notes are due 2033
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
IBM $3.25 billion, €4.25 billion and £750 million notes offering
The investment-grade debt consists of nine tranches of notes
Norwegian Cruise Line $600 million senior secured notes offering
The senior secured notes are due 2028
TP Global Operations acquisition of Truphone’s non-Russian business and assets
We advised the acquirer of Truphone’s assets in a pre-packaged English administration
Israel Discount Bank $800 million senior notes
We advised Israel Discount Bank on its debut Rule 144A / Regulation S senior notes offering